Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabella Castellano

Showing results (71-80 of 136) with videos related to

Pageof 14
Sort By:
Cancers|June 7, 2020
DSCAM-AS1-Driven Proliferation of Breast Cancer Cells Involves Regulation of Alternative Exon Splicing and 3'-End UsageJamal Elhasnaoui, Valentina Miano, Giulio Ferrero, et al.
Medical Oncology (Northwood, London, England)|May 10, 2021
Hypofractionated breast irradiation: a multidisciplinary review of the Senonetwork study groupBruno Meduri, Fiorenza De Rose, Carlo Cabula, et al.
International Journal of Molecular Sciences|December 30, 2020
Is There a Place for Immune Checkpoint Inhibitors in Vulvar Neoplasms? A State of the Art ReviewFulvio Borella, Mario Preti, Luca Bertero, et al.
Journal of Clinical Pathology|June 8, 2014
A new clinical cut-off of cytokeratin 19 mRNA copy number in sentinel lymph node better identifies patients eligible for axillary lymph node dissection in breast cancerCristina Deambrogio, Isabella Castellano, Alessia Paganotti, et al.
Nutrients|November 14, 2023
Impact of Caloric Restriction in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Prospective Case Control StudyIsabella Castellano, Francesco Gallo, Paola Durelli, et al.
The Journal of Pathology|July 19, 2012
Spontaneous and pronase-induced HER2 truncation increases the trastuzumab binding capacity of breast cancer tissues and cell linesDaniele Recupero, Lorenzo Daniele, Caterina Marchiò, et al.
Endocrine|April 14, 2017
Histopathological and genetic characterization of aldosterone-producing adenomas with concurrent subclinical cortisol hypersecretion: a case seriesFrancesco Fallo, Isabella Castellano, Celso E Gomez-Sanchez, et al.
Breast Cancer Research and Treatment|February 4, 2010
Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancersIsabella Castellano, Elena Allia, Valeria Accortanzo, et al.
Oncotarget|December 31, 2015
p130Cas scaffold protein regulates ErbB2 stability by altering breast cancer cell sensitivity to autophagyBrigitte Bisaro, Marianna Sciortino, Shana Colombo, et al.
The British Journal of Radiology|February 27, 2020
Intraoperative breast specimen assessment in breast conserving surgery: comparison between standard mammography imaging and a remote radiological systemGiovanna Mariscotti, Manuela Durando, Luca Jacopo Pavan, et al.
Pageof 14

Showing results (71-80 of 136) with videos related to

Sort By:
Pageof 14
Cancers|June 7, 2020
DSCAM-AS1-Driven Proliferation of Breast Cancer Cells Involves Regulation of Alternative Exon Splicing and 3'-End UsageJamal Elhasnaoui, Valentina Miano, Giulio Ferrero, et al.
Medical Oncology (Northwood, London, England)|May 10, 2021
Hypofractionated breast irradiation: a multidisciplinary review of the Senonetwork study groupBruno Meduri, Fiorenza De Rose, Carlo Cabula, et al.
International Journal of Molecular Sciences|December 30, 2020
Is There a Place for Immune Checkpoint Inhibitors in Vulvar Neoplasms? A State of the Art ReviewFulvio Borella, Mario Preti, Luca Bertero, et al.
Journal of Clinical Pathology|June 8, 2014
A new clinical cut-off of cytokeratin 19 mRNA copy number in sentinel lymph node better identifies patients eligible for axillary lymph node dissection in breast cancerCristina Deambrogio, Isabella Castellano, Alessia Paganotti, et al.
Nutrients|November 14, 2023
Impact of Caloric Restriction in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Prospective Case Control StudyIsabella Castellano, Francesco Gallo, Paola Durelli, et al.
The Journal of Pathology|July 19, 2012
Spontaneous and pronase-induced HER2 truncation increases the trastuzumab binding capacity of breast cancer tissues and cell linesDaniele Recupero, Lorenzo Daniele, Caterina Marchiò, et al.
Endocrine|April 14, 2017
Histopathological and genetic characterization of aldosterone-producing adenomas with concurrent subclinical cortisol hypersecretion: a case seriesFrancesco Fallo, Isabella Castellano, Celso E Gomez-Sanchez, et al.
Breast Cancer Research and Treatment|February 4, 2010
Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancersIsabella Castellano, Elena Allia, Valeria Accortanzo, et al.
Oncotarget|December 31, 2015
p130Cas scaffold protein regulates ErbB2 stability by altering breast cancer cell sensitivity to autophagyBrigitte Bisaro, Marianna Sciortino, Shana Colombo, et al.
The British Journal of Radiology|February 27, 2020
Intraoperative breast specimen assessment in breast conserving surgery: comparison between standard mammography imaging and a remote radiological systemGiovanna Mariscotti, Manuela Durando, Luca Jacopo Pavan, et al.
Pageof 14